Skip to content

Viatris VTRS Greater China — Net Sales

Other segment segments

Developed Markets Segment
$2.03B+6.7%
Emerging Markets Segment
$537.4M+2.7%
Japan, Australia and New Zealand Segment
$273.5M-1.3%

Similar metrics at other companies

USANA Health Sciences logo
USNAGreater China — Net Sales
$123.33M+3.9%
NovoCure logo
NVCRGreater China — Net revenues
$4.8M+3.9%
Apple logo
AAPLGreater China — Net Sales
$20.5B+28.1%
Tapestry, Inc. logo
TPRGreater China — Net Sales
$432.2M+55.0%
Imax logo
IMAXGreater China — Revenue
$20.57M-48.7%
Unity Software logo
UGreater China — Revenue
$100.59M+54.3%

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$18.49B+81.7%
Enterprise value$31.3B+29.5%
P/S1.3×+0.5×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's greater china — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's greater china — net sales?
Viatris (VTRS) reported greater china — net sales of $680.1M in Q1 2026.
How has Viatris's greater china — net sales changed year-over-year?
Viatris's greater china — net sales increased by 22.4% year-over-year, from $555.5M to $680.1M.
What is the long-term trend for Viatris's greater china — net sales?
Over 4 years (2021 to 2025), Viatris's greater china — net sales has grown at a 1.3% compound annual growth rate (CAGR), from $2.21B to $2.33B.
What does greater china — net sales mean?
Represents the total revenue generated from the sale of pharmaceutical products and services within the Greater China geographic region. This metric reflects the market demand and commercial success of the company's portfolio in this specific territory.